SCR-1481B1 |
Katalog-Nr.GC19108 |
SCR-1481B1 (c-Met-Inhibitor 2) ist eine potente Verbindung, die eine AktivitÄt gegen Krebs hat, die von der Met-Aktivierung abhÄngt, und die auch als VEGFR-Inhibitor eine AktivitÄt gegen Krebs hat.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1174161-86-4
Sample solution is provided at 25 µL, 10mM.
SCR-1481B1 (c-Met inhibitor 2) is a potent compound that has activity against cancers dependent upon Met activation and also has activity against cancers as a VEGFR inhibitor.
More details please refer to Patent WO 2009094417 A1.
References:
[1]. Robert M. Borzilleri, et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *